SEC Filing

Investor Contacts

Andrea N. Flynn, Ph.D. 
Vice President, Head,
Investor Relations

investorinfo@jazzpharma.com
Ireland: +353 1 634 7892
U.S.: +1 650 496 2800

SEC Filing Details

Document Details

Form
Filing Date
Jul 23, 2008
Document Date
Jul 21, 2008
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Jazz Pharmaceuticals plc
Issuer
JAZZ PHARMACEUTICALS PLC
Filer
COLELLA SAMUEL D